RCG2018 header

The 8th Red Cell Genotyping Symposium will be held on September 12,  2018 at the National Institutes of Health in Bethesda, MD.  Registration is now open!

Final schedule

 This year's Red Cell Genotyping Symposium will be held in the Natcher Ruth Kirschstein Auditorium, National Institutes of Health, Bethesda, MD.

 Scientific Committee
Willy A. Flegel, MD – National Institutes of Health, Bethesda, MD
Disclosure: RHD genotyping royalty recipient and intellectual property right owner

Gregory A. Denomme, PhD, FCSMLS(D) – Versiti, Milwaukee, WI
Disclosures: Grifols, SA – Speaker’s Bureau, Honorarium; Ortho Clinical Diagnostics– Speaker’s BureauHonorarium ; AABB Press – Author, Honorarium

 Activity Director
Jerome L. Gottschall, MD – Versiti, Milwaukee, WI
No relationship to disclose

Symposium Coordinators
Sue Johnson, MSTM, MT(ASCP)SBB – Versiti, Milwaukee, WI
Karen Byrne, MS, MT(ASCP)SBB – National Institutes of Health, Bethesda, MD
Carrie Kapczynski – Versiti, Milwaukee, WI
Coordinators are not involved with content

Scheduled Speakers
Chris Miskel, BS, MBA – President and CEO, Versiti, Milwaukee, WI
No relationship to disclose

Jeanne E. Hendrickson, MD – Yale School of Medicine, New Haven, CT
No relationship to disclose

Shelley Sahu, MD – NIH Clinical Center, Bethesda, MD
No relationship to disclose

Eric Gehrie, MD – Johns Hopkins Medical Institutions, Baltimore, MD
No relationship to disclose

Mazen Toushan, MD – Versiti, Milwaukee, WI  
No relationship to disclose

Patrick Trépanier, PhD, MBA – Héma-Québec, Québec, Canada
No relationship to disclose

Diarmaid P. O’Donghaile, MD, FRCPath – Irish Blood Transfusion Service, Dublin, Ireland
No relationship to disclose

Waseem Q. Anani, MD – Versiti, Milwaukee, WI
No relationship to disclose

Jill Johnsen, MD – Bloodworks Northwest, Seattle, WA
No relationship to disclose

S. Gerald Sandler, MD – Georgetown University, Georgetown, MD
No relationship to disclose

Moderators
Willy A. Flegel, MD – National Institutes of Health, Bethesda, MD
Gregory A. Denomme, PhD, FCSMLS(D) – Versiti, Milwaukee, WI
Jerome L. Gottschall, MD – Versiti, Milwaukee, WI
Courtney D. Fitzhugh, MD – NIH, Bethesda, MD
No relationship to disclose

Learning Objectives
1. Discuss how advances in molecular immunohematology are changing patient care.
2. Discuss patient care strategies from examples (vignettes) described during case reviews.
3. Review the fundamentals of the molecular basis for blood group antigen expression.
4. Identify red cell genotyping strategies to prevent alloimmunization.
5. Discuss the future of red cell genotyping in personalized transfusion medicine and its role in improving patient care.

ACCME Accreditation Statement:
BloodCenter of Wisconsin is accredited by the Accreditation Council for ContinuingMedical Education (ACCME) to provide continuing medical education to physicians.

AMA Credit Designation Statement:
BloodCenter of Wisconsin designates this Live Activity for a maximum of 6 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of theirparticipation in the activity.

Hours of Participation for Allied Health Care Professionals BloodCenter of Wisconsin designates this activity for up to 6hours of participation for continuing education for allied health professionals.

BloodCenter of Wisconsin is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.

 

Registration Fee: $95.00

Please allow sufficient time to pass through NIH security

This is the enrollment area for NIH and FDA employees only. This requires a code for enrollment. Please contact Karen Byrne -  kbyrne@cc.nih.gov   to access the enrollment code.